The Limited Times

Now you can see non-English news...

Covid-19: Blood clots should be listed as "very rare" side effect of AstraZeneca vaccine, says European Medicines Agency


In a statement, however, the Amsterdam-based agency said the risk / benefit balance remained "positive".

The European Medicines Agency (EMA) said on Wednesday that blood clots should be listed as a "very rare" side effect of the AstraZeneca vaccine against Covid-19.

Read also: A lead to explain the rare thromboses linked to the AstraZeneca vaccine

The EMA has established "a possible link with very rare cases of unusual blood clots with low blood platelets," the Amsterdam-based agency said in a statement, indicating, however, that the benefit / risk balance remains "positive".

Source: lefigaro

All business articles on 2021-04-07

You may like

Trends 24h

Business 2021-04-14T19:05:00.019Z


© Communities 2019 - Privacy